Treatment of Steroid Non-responsive Acute GVHD With Alpha 1 Antitrypsin (AAT). A Phase I/II Study

Trial Profile

Treatment of Steroid Non-responsive Acute GVHD With Alpha 1 Antitrypsin (AAT). A Phase I/II Study

Completed
Phase of Trial: Phase I/II

Latest Information Update: 29 May 2017

At a glance

  • Drugs Alpha 1-antitrypsin (Primary)
  • Indications Graft-versus-host disease
  • Focus Adverse reactions; Proof of concept; Therapeutic Use
  • Most Recent Events

    • 22 May 2017 Status changed from active, no longer recruiting to completed.
    • 06 Mar 2017 Status changed from recruiting to active, no longer recruiting.
    • 18 Nov 2016 Planned primary completion date changed from 1 Dec 2016 to 1 Jul 2017.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top